 NEW YORK, NY ACCESSWIRE May 13, 2020 Pomerantz LLP is investigating claims on behalf of investors of LogicBio Therapeutics, Inc. LogicBio or the Company LOGC. Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. The investigation concerns whether LogicBio and certain of its officers andor directors have engaged in securities fraud or other unlawful business practices. 